InFintT Acquisition Corp
NYSE:IFIN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InFintT Acquisition Corp
NYSE:IFIN
|
US |
|
Haisco Pharmaceutical Group Co Ltd
SZSE:002653
|
CN |
|
H
|
Hengxin Technology Ltd
HKEX:1085
|
CN |
Income Statement
Earnings Waterfall
InFintT Acquisition Corp
Income Statement
InFintT Acquisition Corp
| Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||
| Operating Expenses |
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
|
| Selling, General & Administrative |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(3)
|
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Operating Income |
(3)
N/A
|
(4)
-34%
|
(4)
-4%
|
(3)
+18%
|
(3)
+16%
|
(2)
+29%
|
(2)
+13%
|
(2)
-2%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
1
|
3
|
5
|
5
|
6
|
5
|
4
|
4
|
|
| Pre-Tax Income |
(2)
N/A
|
(1)
+38%
|
0
N/A
|
2
+472%
|
3
+43%
|
3
+7%
|
3
-13%
|
2
-20%
|
|
| Net Income | |||||||||
| Income from Continuing Operations |
(2)
|
(1)
|
0
|
2
|
3
|
3
|
3
|
2
|
|
| Net Income (Common) |
(2)
N/A
|
(1)
+38%
|
0
N/A
|
2
+472%
|
3
+43%
|
3
+7%
|
3
-13%
|
2
-20%
|
|
| EPS (Diluted) |
-0.08
N/A
|
-0.04
+50%
|
0.02
N/A
|
0.13
+550%
|
0.2
+54%
|
0.2
N/A
|
0.22
+10%
|
0.2
-9%
|
|